<div id="readability-page-1"><div><p><span>Atlas Venture Fund X LP, Beneficial Owner of Kymera Therapeutics Inc [KYMR], filed a Form 144 on December 10, 2025 with the Securities and Exchange Commission proposing to sell restricted securities:</span></p><div><table><tbody><tr><td><span>Approximate Date Of Sale</span></td><td><span>12/10/25</span></td></tr><tr><td><span>Shares</span></td><td><span>193,040</span></td></tr><tr><td><span>Broker</span></td><td><span>BTIG LLC</span></td></tr></tbody></table></div><p><span>Prior to the sale of restricted stock, owners must file a Form 144 with the SEC.  Upon submission of the filing to the SEC the owner is permitted to sell the shares, or any fraction thereof, within 90 days.</span></p><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

KYMR

<p>Atlas Venture Fund X LP filed a Form 144 with the SEC to sell 193,040 shares of Kymera Therapeutics Inc on December 10, 2025. The sale is facilitated by BTIG LLC, and the shares can be sold within 90 days of filing. This is a significant corporate event for Kymera Therapeutics.</p>

Owner Atlas Venture Fund X LP Files To Sell 193,040 Of Kymera Therapeutics Inc [KYMR]